Clinical trial
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in subjects with Gastroesophageal Reflux Disease (GERD) with Persistent Regurgitation W
To evaluate the effect of 3 doses of SSP-002358 on the symptom of regurgitation compared with placebo
| Category | Value |
|---|---|
| Study start date | 2012-04-17 |